What happened
Grant cancellations at leading research institutions appear to target the study of the impacts of racism on brain health A new round of scientific grant cancellations has hit brain health and Alzheimer’s disease research at two leading research institutions, Emory University and the University of Pittsburgh.
Why it matters
AtlasHour context: this story may affect public policy, global affairs, business confidence, technology direction, energy security, or civic life.
Global context
The story is being tracked through Global Markets.
Who is affected
Global Markets
What to watch next
Readers should watch official responses, local reaction, source updates, and whether the story changes the next decision cycle.
The consequence layer
AtlasHour context: this story may affect public policy, global affairs, business confidence, technology direction, energy security, or civic life.
What To Watch Next
Three facts to keep in view
The Guardian
Designed for a concise world-news brief.
Used for editorial story mapping and source context.
Related Stories
What is Ebola and why is the outbreak in DRC causing so much concern?
Strain of virus with no vaccine has potential to overrun response impeded by conflict and misinformation Health authorities in the Democratic Republic of the Congo are losing their battle to contain the country’s deadliest Ebola outbreak. DRC’s health ministry declared an outbreak in Ituri province on 15 May, though sequencing shows it had begun in February. It has since spread to five other provinces and is on track to overtake the 2014-16 west Africa outbreak as the largest in history...
How Louisiana’s New Surgeon General Wants to Transform Public Health
Dr. Evelyn Griffin is pushing for more emphasis on wellness and prevention. She has also aligned with the MAHA movement in fighting government mandates and questioning the safety of some vaccines.
How One Woman With a Very Rare Disease Secured a Clinical Trial
Through sheer determination, Neena Nizar has become the first patient in a clinical trial testing a treatment for her disease — one so rare it affects just 30 people worldwide.
AtlasHour updates articles as new verified information becomes available. Corrections and source context can be sent to the newsroom.